US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist
  • 1.4700
  • -0.0800-5.16%
Close Feb 28 16:00 ET
  • 1.4700
  • 0.00000.00%
Post 16:05 ET
25.80MMarket Cap-2.94P/E (TTM)

About Lexaria Bioscience Company

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.

Company Profile

SymbolLEXX
Company NameLexaria Bioscience
Listing DateJan 12, 2021
Founded2004
CEOMr. Richard C. Christopher
MarketNASDAQ
Employees7
Fiscal Year Ends08-31
Address740 McCurdy Road,Suite 100
CityKelowna
ProvinceBritish Columbia
CountryCanada
Zip CodeV1X 2P7
Phone1-250-765-6424

Company Executives

  • Name
  • Position
  • Salary
  • Richard C. Christopher
  • Chief Executive Officer
  • 519.32K
  • Michael Elliot Shankman
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • John M. Docherty
  • Director; President and Chief Scientific Officer of the Company and Its Subsidiaries
  • 414.42K
  • Christopher Bunka
  • Chairman of the Board
  • 884.84K
  • Baljinder Kaur Bhullar
  • Independent Director
  • --
  • William Edward McKechnie
  • Independent Director
  • 69.83K
  • Albert L. Reese, Jr
  • Independent Director
  • 74.83K
  • Nicholas W. Baxter
  • Independent Director
  • 74.83K